It has been hypothesized that environmental exposure to synthetic estrogenic chemicals and related endocrine-active compounds may be responsible for a global decrease in sperm counts, decreased male reproductive capacity, and breast cancer in woomen. 
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In 1993, Colborn et al. (1) pointed out that large amounts of industrial-derived endocrine-disrupting chemicals have been released into the environment since world War II, and they hypothesized that prenatal or early postnatal exposure to these compounds could result in permanent and irreversible damage to wildlife and humans. Several studies on wildlife populations have documented adverse effects that correlate with exposure to one or more putative endocrine-disrupting chemicals (2-9); however, in many instances it is difficult to assign causality because of the complexity of environmental contaminants and the lack of analytical data that document contaminant levels during critical windows of exposure. Nevertheless, there have been several incidents in wildlife populations that strongly correlate with exposure to specific industrial chemicals; this includes alligators in Lake Apopka, Florida, exposed to a spill of organochlorine pesticides from a chemical waste site (5, 8, 9) . The alligators display a host of morphologic and hormonally related abnormalities of the male and female reproductive tracts, including reduced penis size in males. This reduced penis size in male alligators (5, 8, 9 ) and a report (10) which suggested that sperm counts had decreased globally (from 113 x 106 to 66 x 106/mL) during 1938-1990 generated considerable public, media, regulatory, and scientific concern about the possible role of environmental exposures to endocrine disruptors and their role in decreased male reproductive capacity and breast cancer in women. In 1995, I critically reviewed the endocrine-disruptor hypothesis; based on the available data, I was highly skeptical about the causal linkage between exposure to environmental (industrial-derived) endocrine disruptors and adverse human health effects (11) . Some of this skepticism was related to the relatively low levels of exposure to synthetic endocrine disruptors, particularly those with estrogenic activity (xenoestrogens), as compared to high dietary concentrations of naturally occurring endocrine-active compounds in fruits and vegetables and their derived food products. Since 1995, the endocrine-disruptor hypothesis has spurred new scientific studies that address several relevant issues, and I will highlight and discuss these in this paper. In addition, the National Research Council has published a comprehensive report on "Hor-monally Active Agents in the Environment" (12) .
Wildlife and Laboratory Animal Studies
The effects of environmental endocrine disruptors on wildlife populations are being extensively investigated; adverse developmental and reproductive effects have been primarily linked to organochlorine compounds such as polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-dioxins (PCDDs), and polychlorinated dibenzofurans (PCDFs), as well as alkylphenols derived from alkylphenol ethoxylate (AE) surfactants. Persistent organochlorine pollutants (POPs), including both pesticides such as DDT/DDE and PCBs, were among the first industrial compounds identified in the environment. Moreover, with improvement of analytical techniques, an ever-increasing number of structurally diverse POPs have been detected in environmental samples at low concentrations (2, 6, 13, 14) . The use and production of DDT and PCBs were restricted and banned in most countries in the 1970s; however, these compounds are still the most abundant POPs in most wildlife and human samples, even though their concentrations have significantly decreased over the past 30 years (14) (15) (16) . Lower concentrations of POPs in the Great Lakes region are correlated with "dramatic improvements in reproductive success and significant increases in populations of cormorants, gulls, terns, herons and other predatory birds in the Great Lakes basin" (16) .
There has been particular concern about the discharge and environmental persistence of AEs and their alkylphenol degradation products, which have been identified in relatively high concentrations in industrial sewage effluents and in sediments in lakes and rivers in Europe (4, (17) (18) (19) (20) (21) . Concentrations of these compounds in North American rivers and sediments tend to be lower. Soto et al. (20) showed that nonylphenols extracted from polystyrene were estrogenic, and Jobling and Sumpter (17) Decreased Male Reproductive Capacity and Endocrine Disruptors Sperm counts. The concern over decreased sperm counts and male reproductive capacity was triggered by a paper on the metaanalysis of 61 sperm count studies which concluded that "There has been a genuine decline in semen quality over the past 50 years" (10) . This study (10) and a subsequent paper (42) hypothesized that We argue that the increasing incidence of reproductive abnormalities in the human male may be related to increased oestrogen exposure in utero.
PCBs and TCDD-like compounds, as well as DDE, may also contribute to this problem (42, 43) . The validity of the meta-analysis (10) In contrast, using a similar approach, Bujan et al. (50) reported that from 1977 to 1992, "sperm concentration has not changed with time in the Toulouse area." In 1996, Fisch et al. (59) reported that semen quality of 1,283 men from three sperm banks in the United States had not declined over the last 25 years . The surprising results of this study were the large demographic differences in sperm counts: sperm donors from New York had the highest number (131.5 ± 3.5 x 106/mL, mean ± SEM), followed by Minnesota (100.8 ± 2.9 x 106/mL) and California (72.7 ± 3.1 x 106/mL).
In a separate study, Paulsen et al. (54) (61) and Danish men (62) and also in a Canadian study among 11 academic fertility centers (63) . The (63) ; however, when the data from 1975 to 1983 were induded, "there was no significant trend in sperm density" (63) . The analysis of data from the individual centers (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) Sharpe and Skakkebak (42) , suggested that decreased male reproductive capacity may be related to exposure to endocrine disruptors (42) , and pointed out that some studies reported increases in hypospadias and cryptochidism in male infants. Paulozzi (67) analyzed international trends in rates of cryptorchidism and hypospadias from several different countries and categorized regions by gross domestic product (in 1984). Hypospadias increased in more affluent areas but not in less affluent areas up to 1985, whereas no increases have been observed since 1985. Before 1985, there were also region-specific trends in rates of cryptorchidism (increases in two U.S. and one South American system); however, since 1985, rates have actually declined in most systems (67) . Thus, the specter of a global decrease in male reproductive capacity is not supported by international trends for hypospadias or cryptorchidism; however, like the sperm count data, there is some evidence that incidence of these problems is also dependent on demography.
Testicular cancer. Testicular cancer is one of the major types of cancer in young men, and there is evidence suggesting a prenatal etiology (68) . Cryptorchidism is one of the known risk factors for testicular cancer, suggesting that in utero or early postnatal exposure to estrogens or antiandrogens may contribute to development of this tumor in young men (68) (69) (70) (71) (72) . Testicular cancer is generally increasing in most countries, and it was suggested that p,p'-DDE, an antiandrogen, could play a role in the development of this cancer (43) . However, Ekbom et al. (15) pointed out that DDE concentrations in breast milk in the four Scandinavian countries are not significantly different, whereas the incidence of testicular cancer (1985) (1986) (1987) (1988) (1989) Sex ratios and endocrine disruptors. A recent study (74) reported that accidental exposure to high concentrations of TCDD in Seveso resulted in lower sex ratios (male/female) at birth; this observation has been noted for high level occupational exposures to some chemicals (74) (75) (76) . There is evidence from several countries, including a recent U.S. study, that in the past few decades there have been small but significant decreases in sex ratios (77) (78) (79) . The potential role of male/female sex ratios as sentinel health indicators "that may be linked to environmental factors" was proposed by Davis et al. (80) (84) reported that fertility of DES-exposed males was not significantly different from males in a control group. DES was not used in Finland, but in a recent study, Hemminki et al. (85) reported reproductive effects of in utero exposure to estrogen and progestin drugs on male and female offspring. There were some differences in times of birth between controls and hormone-or drugexposed individuals (e.g., time to first birth after marriage, mean time between first and second live birth); however, the overall fertility in both groups was similar. Hemminki et al. (85) conduded that Estrogen-and progestin-containing drugs as used in the study population did not have much impact on the fertility of offspring.
Thus, pharmacologic doses of estrogenic drugs did not affect fertility, and it is unlikely that much lower concentrations of weakly estrogenic industrial compounds would affect fertility. Thus, with the exception of testicular cancer, data from more recent studies suggest that there does not appear to be a worldwide decrease in disorders of the male reproductive tract.
Xenoestrogens and Breast Cancer
In 1992-1993, two studies from Connecticut and New York reported higher concentrations of PCBs and DDE, respectively, in breast cancer patients as compared to controls (86, 87) ; this generated the hypothesis that xenoestrogens, such as PCBs and DDE, were preventable causes of breast cancer (88) . This hypothesis was supported by the two studies on breast cancer patients (86, 87) and also by in vitro metabolic data on chemical-induced metabolism of E2 to 2-hydroxyestrone (2-OHEI) and 16ax-hydroxyestrone (16a-OHE1) metabolites in MCF-7 human breast cancer cells (89) . The hypothesis of Davis et al. (88) Sprague-Dawley rats (33, 94) ; this was consistent with the antiestrogenic activity associated with AhR agonists in breast cancer (95, 96 PCBs, DDE, and other weakly estrogenic pesticides induced higher 166a-OHE1/2-OHE1 ratios, and these data were initially used to support the xenoestrogen hypothesis in early reports showing higher concentrations of PCBs or DDE in breast cancer patients versus controls. The predictive utility of the ratio was based on reports that 16a-OHE1 was highly estrogenic and higher levels of this metabolite were observed in a small cohort of breast cancer patients (89, 109, 110) . In contrast, 2-OHE1 exhibits partial antiestrogenic activity and was labeled by Bradlow et al. as "the 'good' estrogen" (110) . In my laboratory, we used the radiometric assay, as previously described (89), to investigate the effects of a diverse spectrum of estrogens, antiestrogens, and mammary carcinogens on estrogen metabolism (111, 112) . The results showed that the metabolite ratios in our study were not predictive of carcinogens, estrogens, or antiestrogens, and metabolite ratios varied with the concentration of some compounds in this assay. For example, the triphenylethylene antiestrogen 4'-hydroxytamoxifen decreased the ratio, whereas the potent steroidal antiestrogen ICI 182,780 increased the ratio; we also observed other inconsistencies between compounds with similar effects on mammary cancer (111, 112) . We concluded that induction of this metabolite ratio in MCF-7 breast cancer cells was not predictive for a wide variety of chemicals that may affect breast cancer in vivo (112) . Some additional studies question the use of the urinary 16a-OHE1/2-OHE1 ratio as a predictor of risk for breast cancer (113) (114) (115) . In a recent study, Ursin et al. (115) reported that in 66 postmenopausal breast cancer patients and 76 control subjects, the ratio of 2-OHEI to 16a-OHE1 was 1.1% higher in the patients (p = 0.84) contrary to the hypothesis. (116) (Figure 1 ). The reconstituted mixture in this study included the following weakly estrogenic organochlorine contaminants: Recent reports have investigated serum concentrations of some phytoestrogens (119, 120) , and these can be compared to endogenous hormone and organochlorine xenoestrogen serum concentrations in human populations. A recent study on women in Long Island, New York, showed that total serum concentrations of organochlorine pesticides plus PCBs were < 10 ng/mL (121) ; these values correspond to serum concentrations from women sampled within the last 5-10 years (Table 1) . Setchell et al. (119) recently summarized serum concentrations of endogenous estrogenic hormones in men, women, and children as well as concentrations of estrogenic isoflavones in various groups. Serum concentrations of estradiol in men, women, and neonates are variable (between 10 and 500 pg/mL); however, concentrations in maternal blood and cord blood are similar to concentrations of organochlorine compounds (10,000 pg/mL). On the basis of the low estrogenic potencies of these xenoestrogens, it is unlikely that their effects as estrogens are important. This does not exclude endocrine-and estrogen-independent toxic actions of organochlorine compounds that are currently being investigated in several laboratories. Serum concentrations of estrogenic isoflavones (primarily genistein, daidzein, and equol) can range from 552,000 to 1,755,000 pg/mL (mean = 988,000 pg/mL) in soy-fed infants; these are approximately 100-fold higher than organochlorine concentrations (119) . High isoflavone concentrations (-100,000 pg/mL) have also been detected in Japanese men (119, 120) . Thus, on the basis of current analytical data, soy-fed infants are the group with the highest exposure to estrogenic compounds during critical periods of development. Most studies associate consumption of phytoestrogen-containing foods with health benefits (122,123) 
